United States · 
What does Delphi Ventures invest in?
Delphi Ventures invests most often at Series C and Seed (39% of the rounds on record), in sectors such as Apps, Audio and Consumer.
Delphi Ventures highlights
- 01
125 rounds on record
- 02
Mostly Series C and Seed: 39% of its rounds
- 03
Sole investor in 6 rounds, median $20M
- 04
15 exits from the portfolio
What they do
Filed 1 private fund offerings with the SEC, the most recent in 2026-05From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- GrowthPre-seedSeedSeries ASeries B
- Sectors
- AppsAudioConsumer
- Based in
- San Mateo, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first125 appearances
- 2025
6 rounds
- Oct
- Sept
- Jul
- Jun
- Apr
- Apr
- 2024
9 rounds
- Nov
- Nov
- Oct
- Aug
- Apr
- Mar
- Feb
- Feb
- Feb
- 2023
7 rounds
- Oct
- Sept
- Jun
- May
- Apr
- Mar
- Feb
- 2022
10 rounds
- Nov
- Nov
- Oct
- Jul
- Mar
- Jan
- Jan
- Jan
- Jan
- Jan
- 2021
3 rounds
- Nov
- Oct
- Jul
- 2015
1 round
- May
- 2014
5 rounds
- Sept
- Jul
- Jun
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration11 named
ALAnil LullaMemberiForm ADV
ATAugustus Tye MerloExecutive OfficeriFiling they signed
DADrew Austin HendersonExecutive OfficeriFiling they signed
KKKevin KellyMemberiForm ADV
LSLuke SaundersMemberiForm ADV
MDMedio DemarcoMemberiForm ADV
PCPiers Charles KicksDirectoriFiling they signed
SHSarah Helena BrennanExecutive OfficeriFiling they signed
TAThomas Andrew Shaughnessy JrDirectoriFiling they signed
TSThomas ShaughnessyMember; ManageriForm ADV
YLYan LibermanMember; ManageriForm ADV
We also hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$33Mgross assets of its fundsOct 2026
1+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
- Legal name
- Delphi Ventures General Partner LLC
- SEC number
- CRD 320814
Exits from the portfolio
Companies it backed that were later bought or listed15 in all
Pivot MedicalBought by Stryker CorporationUndisclosedJan 2014
Karyopharm TherapeuticsListedUndisclosedNov 2013
OncoMed PharmaceuticalsListed$82MJul 2013
BarosenseBought by Boston ScientificUndisclosedJul 2013
PTC TherapeuticsListed$125MJun 2013
Cameron HealthBought by Boston ScientificUndisclosedJun 2012
KAI PharmaceuticalsBought by Amgen$315MApr 2012
BARRX MedicalBought by Covidien$325MNov 2011
Aragon SurgicalBought by AesculapUndisclosedSept 2011
AcclarentBought by Johnson & Johnson$785MDec 2009
Primaeva MedicalBought by Syneron Medical$30MOct 2009
EvalveBought by Abbott Labs$410MSept 2009
Reliant TechnologiesBought by Thermage$66MJan 2009
LipoSonixBought by Medicis Pharmaceutical$300MJun 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.